MarnieRenee(Sambur)RobinsonMD

PubMed

• 3 citations
  Stone Forming Risk Factors in Patients With Type Ia Glycogen Storage Disease
  Charles D. Scales, Aravind Chandrashekar, Marnie R. Robinson, David A. Cantor, Jennifer A. Sullivan, George E. Haleblian, Victor A. Leitao, Roger L. Sur, Kristy M. Bor...> ;The Journal of Urology. 2010 Mar 1
• 50 citations
  Impact of Long-Term Potassium Citrate Therapy on Urinary Profiles and Recurrent Stone Formation
  Marnie R. Robinson, Victor A. Leitao, George E. Haleblian, Charles D. Scales, Aravind Chandrashekar, Sean A. Pierre, Glenn M. Preminger> ;The Journal of Urology. 2009 Mar 1
• 37 citations
  Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis.
  George E. Haleblian, Victor A. Leitao, Sean A. Pierre, Marnie R. Robinson, David M. Albala, Anthony A. Ribeiro, Glenn M. Preminger> ;Journal of Endourology. 2008 Jun 25
• 20 citations
  Urolithiasis: not just a 2-legged animal disease.
  Marnie R. Robinson, Regina D. Norris, Roger L. Sur, Glenn M. Preminger> ;The Journal of Urology. 2008 Jan 1
• 2 citations
  Novel techniques for the treatment of localized prostate cancer: evidence of efficacy?
  Marnie R. Robinson, Judd W. Moul> ;Current Urology Reports. 2007 May 30
• 1 citations
  Sonographic detection of metastatic renal cell carcinoma to the bladder
  Marnie R. Sambur, Stephen E. Strup, Daniel A. Merton, Barry B. Goldberg> ;Journal of Ultrasound in Medicine. 2004 Mar 1
• The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up.
  Tolley DA, Parmar MK, Grigor KM, Lallemand G, Benyon LL, Fellows J, Freedman LS, Grigor KM, Hall RR, Hargreave TB, Munson K, Newling DW, Richards B, Robinson MR, Rose ...> ;J. Urol.. 1996-04-01
• The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cypr...
  Robinson MR, Smith PH, Richards B, Newling DW, de Pauw M, Sylvester R> ;Eur. Urol.. 1995-01-01
• Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer.
  Cooper EH, Armitage TG, Robinson MR, Newling DW, Richards BR, Smith PH, Denis L, Sylvester R> ;Cancer. 1990-09-01
• Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours.
  Hetherington JW, Newling DW, Robinson MR, Smith PH, Adib RS, Whelan P> ;Br J Urol. 1987-03-01
• Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
  Denis L, Keuppens F, Mahler C, Debruyne FM, Weil EH, Lunglmayr G, Newling D, Robinson MR, Richards B, Smith PH> ;Prog. Clin. Biol. Res.. 1987-01-01
• A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III tria...
  Smith PH, Suciu S, Robinson MR, Richards B, Bastable JR, Glashan RW, Bouffioux C, Lardennois B, Williams RE, de Pauw M> ;J. Urol.. 1986-09-01
• The EORTC Phase III trials in prostatic cancer.
  Robinson MR, Smith PH, Macaluso MP, Sylvester R, de Voogt H> ;Prog. Clin. Biol. Res.. 1985-01-01
• Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
  Smith PH, Robinson M, Richards B, Suciu S, De Pauw M, Sylvester R, Denis L> ;Urology. 1984-06-01
• Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia.
  Cooper EH, Pidcock NB, Glashan R, Smith PH, Robinson MR, Richards B, Newling D> ;Clin. Chem.. 1982-07-01
• Hormone therapy in prostatic cancer.
  Smith PH, Akdas A, Mason MK, Richards B, Robinson MR, de Pauw M, Sylvester R> ;Acta Urol Belg. 1980-01-01
• The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil.
  Robinson MR, Smith PH, Macaluso MP, Mulder JH, Martínez-Pinéiro JA, Cifuentes-Delatte L, Bono A, Glashan RW> ;Eur. Urol.. 1977-01-01
• Join now to see all